PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
Laboratory research material
⚠ Important – Acetic Acid Water (AA Water) Handling Notice
Previous product handling guidance identified Acetic Acid Water (AA Water) for the CJC-1295 WITHOUT DAC vial in this bundle. This notice applies ONLY to the CJC-1295 WITHOUT DAC vial — not the other peptide(s) in the bundle.
The manufacturer-specific solvent requirement is awaiting verification. Do not assume that bacteriostatic water is interchangeable. Follow a validated laboratory protocol.
For laboratory research only. Not for human use.
Somatic Axis Complex – A dual-compound bundle centered around growth hormone signaling pathways for research applications.This stack combines a GHRH analog with a GHRP, commonly studied together to explore pulsatile signaling effects in controlled environments.Includes:• CJC-1295 (WITHOUT DAC) 10mg• Ipamorelin 10mgDesigned for research into somatic signaling and peptide interaction models.For research purposes only. Not for human consumption.
No laboratory certificate is published for this product. A report covers only the product and strength it names. Published reports are listed on the Certificates of Analysis page.
Somatic Axis Complex — CJC-1295 (Without DAC) 10mg + Ipamorelin 10mg Research Bundle UK
The Somatic Axis Complex pairs CJC-1295 Without DAC 10mg and Ipamorelin 10mg, two compounds frequently studied together in GH-axis research.
Ipamorelin is often paired with a GHRH analogue because, in the original studies, it released GH without the ACTH or cortisol increases seen with GHRP-6 and GHRP-2 (Raun et al., 1998). The non-DAC form is substantially shorter-acting than the albumin-binding DAC-modified form, supporting research designs where discrete, repeated receptor engagement across the research window is the objective.
Sourcing both compounds as a single-supplier bundle simplifies record-keeping for multi-compound research designs.
Janoshik has independently tested samples of CJC-1295 Without DAC 10mg and Ipamorelin 10mg. Their published Certificates of Analysis report measured content and purity for the tested batches and can be reviewed before purchase. LC-MS identity data is not separately reported on the published certificates, and a certificate applies to the batch it names.
Storage and handling requirements for the components of this bundle are being confirmed with the manufacturer. Please contact ASCEND for the information held for the current stock.
For complete mechanism detail on each compound, see the Ipamorelin and CJC-1295 research guides on the Ascend Peptides UK blog, or the GH axis research peptides category page.
The two compounds target mechanistically distinct receptors on the same pituitary somatotroph cells: CJC-1295 Without DAC acts at the GHRH receptor (GHRHR) through the Gs-cAMP-PKA pathway, while Ipamorelin acts at GHSR-1a (the ghrelin receptor) through the Gq-PLC-IP3-calcium pathway. Both compounds increase GH release, and combined GHRH and GHRP stimulation can interact, so studies that use them together need appropriate controls. The bundle supplies the two products together; it does not imply a combined or synergistic effect, and Ascend Peptides UK does not publish a combined research protocol.
Both CJC-1295 and Ipamorelin appear on the WADA Prohibited List, prohibited at all times.
For in-vitro laboratory research only. Not for human consumption, therapeutic, diagnostic, or clinical use. Not classified as a medicinal product by the MHRA.
Other laboratory research materials supplied by Ascend Peptides UK.
UK same working-day dispatch – Secure payment options –
Laboratory research only
© 2026 by Ascend Peptides Uk.
All products sold by Ascend Peptides UK are intended strictly for laboratory research purposes only. Not intended for human consumption or therapeutic use of any kind.
